Compound Heterozygous MRPS14 Variants Associated With Leigh Syndrome.
Publication Year:
2025
PubMed ID:
40317698
Funding Grants:
Public Summary:
MRPS14 is a gene that provides instructions for making a protein needed for how mitochondria (the “energy producers” in our cells) make other proteins. Problems with this gene can affect how cells produce energy. So far, only one person with a disorder linked to this gene (called COXPD38) had been described.
In this report, we describe another child with two new changes in the MRPS14 gene (each inherited from a different parent). The child showed delays in movement and speech by age 2, along with higher-than-normal levels of certain substances in the blood that can indicate problems with energy production.
Brain scans showed patterns typical of a condition called Leigh syndrome, a disorder that affects the nervous system. Another test confirmed a buildup of lactate, which is also a sign that the mitochondria aren’t working properly.
Lab tests on the child’s cells showed reduced levels of the MRPS14 protein and another important mitochondrial protein (COX2). Altogether, these findings suggest that the genetic changes found in this child are likely the cause of their condition.
Scientific Abstract:
MRPS14 (uS14m) is a nuclear-encoded ribosomal protein important for mitochondria-specific translation. To date, only a single individual with a recessive MRPS14-related disorder (also known as COXPD38) has been reported. We report an additional subject possessing novel compound heterozygous MRPS14 variants (p.Asp37Asn, p.Asn60Asp). The subject presented at 2 years with motor and language delays associated with elevated serum lactate/alanine levels. Brain MRI showed a constellation of signal abnormalities consistent with Leigh Syndrome, while MR spectroscopy had an increased lactate peak. Western blots of fibroblasts showed decreased MRPS14 and COX2 protein levels. These results support the pathogenicity of the MRPS14 variants identified here.